alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EX-10.18(g)



 Exhibit 10.18(g) 

[LOGO] 
 June 6, 2009 

AMENDMENT NO. 1 TO GTA 6-13616 
 Frontier Airlines, Inc.

 Frontier Center One 
 7001 Tower Road 

Denver CO 80249-7312 
 CFM International, Inc.
(“CFM”) and Frontier Airlines, Inc. (“Airline”) have entered into General Terms Agreement No. 6-13616 dated June 30, 2000 (the “Agreement”). The Agreement contains applicable terms and
conditions governing the sale by CFM and the purchase by Airline from CFM of CFM56 series Engines, Modules and Optional Equipment in support of Airline’s acquisition of new aircraft. 

WHEREAS, CFM and Airline now desire to revise certain terms and conditions of the Agreement. 

NOW, THEREFORE, in consideration of the foregoing premises and of the mutual covenants and conditions contained herein, and other good and valuable
consideration. Receipt of which is acknowledged and agreed. 
 CFM and Airline agree as follows: 

 

	1.	Revise GTA Exhibit B.1 “Definitions”, paragraph 20 “Ultimate Life”, as follows 


FROM: 
 20. “Ultimate
Life” of a Part means the approved limitation on use of a Part in cumulative Flight Hours or Flight Cycles, which either CFMI or a U.S. and/or French Government authority establish as the maximum period of allowed operational time for such
Parts in Airline service, with periodic repair and restoration. The term does not include individual Failure from wear and tear or other cause not related to the total usage capability of all such Parts in Airline service.” 

TO: 
 “20.
“Ultimate Life” of a Part means the approved limitation on use of a Part in cumulative Flight Hours or Flight Cycles, which either CFMI or a U.S. and/or French Government authority establish as the maximum period of allowed operational
time for such Parts in Airline service, with periodic repair and restoration. Ultimate Life for LLPs shall be used in the calculation of CFM participation (if any, as solely determined by CFM) of an Engine or Part Failure, however, the term does not
include individual Failure from wear and tear or other cause not related to the total usage capability of all such Parts in Airline service.” 

  
 i 








 Except as noted here, the Agreement remains unchanged. Please indicate your agreement with the foregoing by
signing the original and one (1) copy of this Amendment Number 1 to the Agreement in the space provided below. This Letter Agreement may be executed in counterparts each of which, when taken together, will be deemed to be a single, enforceable
agreement between the parties. 
  

									
	FRONTIER AIRLINES, INC.	 		 	CFM INTERNATIONAL, INC.
					
	By:	 	/s/ [Authorized Signatory]	 		 	By:	 	/s/ Thierry Derrien
					
	Printed Name:	 	[Authorized Signatory]	 		 	Printed Name:	 	Thierry Derrien
					
	Title:	 	[Authorized Signatory]	 		 	Title:	 	VP Contracts
					
	Date:	 		 		 	Date:	 	July 9, 2009


  
 ii
Comment Info: =================

General Comment:Amendment to Joint Application of Iberia L?neas A?reas de Espa?a, S.A. and Iberia L?neas A?reas de Espa?a Sociedad An?nima Operadora for Transfer of Foreign Air Carrier Permit and Related Authorizations
#### § 515.25 Revocation of order refusing to approve a medicated feed mill license application or suspending or revoking a license.

The Commissioner of Food and Drugs (the Commissioner), upon his/her own initiative or upon request of an applicant stating reasonable grounds therefor and if the Commissioner finds that the facts so require, may issue an order approving a medicated feed mill license application that previously has had its approval refused, suspended, or revoked.
**OFFICE OF**  **THE APRNEY**  GENERAL **OF TEXAS**  **AUSTIN**

Honorable CliffordB. 3oones, **President Texae**  **PmArmlogleal** College Lubbcwk, Texas A Dear Slrt

\ Yonr letter of'th ot thlCUspar,tment upon~the your appp~latit% for the singIn paultrynwia' who Is four tJlxld6ilts.<

tisal exgl?a~Blal ia to atlon lntq a mtatenos

We **am ot**  **th,i opiztfon**  **.that the**  **~expression** uns not 80 intendba, but waal rathw, lntenU@.tq tinter authority UPOR the go-rer~ingC~board at the OoU.ege, in I$&; di~aretion,to maploy 

## row studencs~ aRd ay than out of the ibeJnriL~r than a single p0ult~jBWi If, P, IIthe dluaretlOn~ofthe **board, it**  &muld be thonghta&vls~blr. Ws rQLtard,iQ 3.~ &snitiaant that the L@.elaturB~~~~d zhe laiagulu wp~ultrpman* mthsr thti the Ijlural *poultrysLdia~"~

2n this Item. Zn other Item8 folLuwedby pasenthetlaaleqamsaim~cnin the educatiOna appprlatfon bill, whem the intent of the I,egisl&turr is alearly to rsqx%ire t&e breaking down of the ,item into parts, the plural Is unlforlllly wed,HonorableClifford B. Jonea, President, page 2

tollowedbj a numeral In pare&he&a to lndlaate the number of positions ambraaedin the plural designation,1. 0.: Unlreralty of Texas,

appropriation,Item 16, .YBesearoh assistants (J,;,"' ,f$n 18 "StatlbtloaPclerks (3) ,* Item 42 qesearch teohnologlsts ." The use of the efngular "poultryman" in this item must be deemed to be intentional and some meaning attributedto It, .: if possible. The only expmatlon whloh ooaurs to ua la that stated above - that the word *poultryman* me intendedto authorize the hiring of a single individualto do the work, and the pareXIth8tieal Your etude&r" was Intendedas an alternate authorityto break the Item darn into four parts for the emplogment **or** rour students, **Instead** or the single individual. suoh oonstruatlon

gives meaning to both the singularwpoultxymanR and the pareuthetioal. Your studente,Rand doee.not +&hute oontrollingetteot to either. It is llkewlrre aonslstentwith the leglslatlvepolicy of oommlttingto the managingboarda of the **respeotfve** eduo&tlonal**institutions** a discretion to operate the Institutionain euoh manner a.cI to lnsure,the 

### maxlmtamor effioluioyand eeoncmy.
..j **Your8 very**  **truly** ATTORNXY GENHzALOFTlFxlls By&, W. FAlRCHIiJl RwF:ej APPROVRD JAW. 2, 1942 ‘(Slgned)GBRAD

0. MANN ATTOFNEY GENERALOF TEXAS
APPROV?iD

OPINIOIV

COMMITTEE BY B.%B. chainnan~
EXHIBIT
      32.1


CERTIFICATION
      PURSUANT TO 18 U.S.C. SECTION 1350,


AS
      ADOPTED PURSUANT TO SECTION 906 OF THE


SARBANES-OXLEY ACT OF 2002





In 
      connection  with the quarterly report of Avitar,  Inc. (the 
"Company") on Form10-QSB for the period ending March 31, 2007 as filed with
      the
      Securities and Exchange  Commission on the date hereof (the 
"Report"),  I, Peter P.  Phildius, Chief Executive Officer of the
      Company certify,  pursuant to 18 U.S.C. Section 1350, as adopted
      pursuant to Section 906 of the  Sarbanes-Oxley Act of 2002, to my
      knowledge,


that:





(1) The Report fully  complies  with the  requirements  of
      Section 13(a) or15(d) of the Securities Exchange Act of 1934; and





(2)  The  information  contained  in the  Report 
fairly  presents,  in all material  respects,  the 
financial  condition  and results of operations of the Company.





Date:
      May
      15, 2007





/s/
      Peter
      P. Phildius


---------------------


Peter
      P.
      Phildius Chief


Executive
      Officer
#### Michael Wayne RIGGS, Petitioner-Appellant, v. J.W. FAIRMAN, Jr., Warden, Respondent-Appellee.

No. 02-55185.

United States Court of Appeals, Ninth Circuit.

Nov. 30, 2005.

Donald M. Falk, Esq., Mayer, Brown, Rowe & Maw, LLP, Palo Alto, CA, for Petitioner-Appellant.

Craig S. Nelson, Esq., Kyle N. Shaffer, AGCA-Office of the California Attorney General, San Diego, CA, for Respondent Appellee.

Before: SCHROEDER, Chief Judge.

ORDER

Upon the vote of a majority of nonre-cused regular active judges of this court, it is ordered that this case be reheard by the en banc court pursuant to Circuit Rule 35-3. The three-judge panel opinion shall not be cited as precedent by or to this court or any district court of the Ninth Circuit, except to the extent adopted by the en banc court.
```

[Federal Register Volume 77, Number 202 (Thursday, October 18, 2012)]
[Notices]
[Page 64108]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-25802]

-----------------------------------------------------------------------

COMMODITY FUTURES TRADING COMMISSION

Sunshine Act Meetings

AGENCY HOLDING THE MEETING: Commodity Futures Trading Commission.

TIME AND DATE: 10:00 a.m., Friday November 9, 2012.

PLACE: 1155 21st St. NW., Washington, DC, 9th Floor Commission 
Conference Room.

STATUS: Closed.

MATTERS TO BE CONSIDERED: Surveillance and Enforcement Matters. In the 
event that the times or dates of these or any future meetings change, 
an announcement of the change, along with the new time and place of the 
meeting will be posted on the Commission's Web site at http://www.cftc.gov.

CONTACT PERSON FOR MORE INFORMATION: Sauntia S. Warfield, 202-418-5084.

Sauntia Warfield,
Assistant Secretary of the Commission.
[FR Doc. 2012-25802 Filed 10-16-12; 4:15 pm]
BILLING CODE 6351-01-P
```
#### § 573.1020 Yellow prussiate of soda.

Yellow prussiate of soda (sodium ferrocyanide decahydrate: Na4Fe(Cn)6°-10H2O) may be safely used as an anticaking agent in salt for animal consumption at a level not to exceed 13 parts per million. The additive contains a minimum of 99.0 percent by weight of sodium ferrocyanide decahydrate.

[41 FR 38657, Sept. 10, 1976; 41 FR 48100, Nov. 2, 1976]
§ 582.6751 Sodium citrate. ( a ) *Product.* Sodium citrate.
( b ) *Conditions of use.* This substance is generally recognized as safe when used in accordance with good manufacturing or feeding practice.
[41 FR 38657, Sept. 10, 1976. Redesignated at 42 FR 14091, Mar. 15, 1977]
Exhibit 10.9.1**FIRST AMENDMENT TO REPLACEMENT****CARRIER****AGREEMENT**     THIS FIRST AMENDMENT TO REPLACEMENT CARRIER AGREEMENT (this “Amendment”) is made andentered into as of June 28, 2005 by and between by Hartford Fire Insurance Company, HartfordCasualty Insurance Company, and Twin City Fire Insurance Company (collectively “Hartford”), andProformance Insurance Company, (“Proformance”). Capitalized terms used but not defined in thisAmendment have the meanings given them in the Replacement Carrier Agreement between Hartford andProformance dated as of May 6, 2005 (the “Original Agreement”).WITNESSETH     WHEREAS, the Original Agreement memorializes the terms pursuant to which Hartford wouldtransfer to Proformance the obligations of Hartford to offer renewals, the Renewal Rights on theNew Jersey Personal Business as of the Nonrenewal Date and Proformance would acquire the RenewalRights (the “Transaction”).     WHEREAS, Original Agreement contains certain conditions to closing, including, withoutlimitation, the approval of the Commissioner of Banking and Insurance of the State of New Jersey(“Commissioner”) for the Transaction set forth in this Agreement;     WHEREAS, the Commissioner has not yet approved the Transaction and the Original Agreementprovides that either party may terminate the Original Agreement if the Transaction has not closedby July 1, 2005 (the “Termination Date”).     WHEREAS, Hartford and Proformance have agreed to amend the Original Agreement to extend theTermination Date until September 1, 2005     NOW, THEREFORE, in consideration of the foregoing premises and the mutual representations,warranties, covenants and agreements set forth, the parties hereto agree as follows:          1. The date “July 1, 2005” in Section VII(A)(4) of the Original Agreement is deleted in itsentirety and the date “September 1, 2005” is inserted in lieu thereof.          2. Except as otherwise expressly provided by this Amendment, all of the terms, conditions andprovisions of the Original Agreement shall remain the same, and the Original Agreement as amendedhereby, shall continue in full force and effect. This Amendment and the Original Agreement shallbe read and construed as one instrument.          3. This Amendment may be executed in any number of counterparts, each of which will be deemedan original and all of which will be treated as a single instrument. Facsimile signatures will beaccepted as originals.*[THE REST OF THIS PAGE INTENTIONALLY LEFT BLANK]*
 

 
IN WITNESS WHEREOF, the parties have executed this Agreement as of June 28, 2005.     PROFORMANCE INSURANCE COMPANY     By: /s/ James V. Gorman     Name: James V. Gorman
§ 524.590 Diclofenac. ( a ) *Specifications.* Each gram of cream contains 10 milligrams diclofenac sodium.
( b ) *Sponsor.* See No. 000010 in § 510.600(c) of this chapter.
( c ) *Conditions of use in horses* — ( 1 ) *Amount.* Apply a 5-inch (5′′) ribbon of cream twice daily over the affected joint for up to 10 days and rub thoroughly into the hair covering the joint until it disappears.
( 2 ) *Indications for use in horses.* For the control of pain and inflammation associated with osteoarthritis in tarsal, carpal, metacarpophalangeal, metatarsophalangeal, and proximal interphalangeal (hock, knee, fetlock and pastern) joints.
( 3 ) *Limitations.* Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[69 FR 40767, July 7, 2004, as amended at 74 FR 26782, June 4, 2009; 74 FR 47436, Sept. 16, 2009]
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 96-7892

STEVEN G. DAVIS,

Petitioner - Appellant,

versus

HARLEY LAPPIN, Warden, Federal Correctional

Institution,

Respondent - Appellee.

Appeal from the United States District Court for the Eastern District of North Carolina, at Raleigh. Terrence W. Boyle, District

Judge. (CA-96-515-5-HC-BO-2)

Submitted: May 29, 1997 Decided: June 6, 1997

Before NIEMEYER, LUTTIG, and MOTZ, Circuit Judges.

Affirmed by unpublished per curiam opinion.

Steven G. Davis, Appellant Pro Se. Robert Edward Skiver, Assistant

United States Attorney, Raleigh, North Carolina, for Appellee.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

Appellant appeals the district court's orders denying relief

on his 28 U.S.C. § 2241 (1994) petition and denying his motion for

reconsideration. We have reviewed the record and the district

court's orders and find no reversible error. Accordingly, we affirm

on the reasoning of the district court. Davis v. Lappin, No. CA96-515-5-HC-BO-2 (E.D.N.C. Nov. 5 and Dec. 3, 1996). We dispense

with oral argument because the facts and legal contentions are

adequately presented in the materials before the court and argument

would not aid the decisional process.

AFFIRMED
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1000

<S>                                       <C>
<PERIOD-TYPE>                              6-MOS
<FISCAL-YEAR-END>                          JAN-02-2000
<PERIOD-END>                               JUL-04-1999
<CASH>                                           5,873
<SECURITIES>                                         0
<RECEIVABLES>                                    4,671
<ALLOWANCES>                                        23
<INVENTORY>                                      6,614
<CURRENT-ASSETS>                                21,960
<PP&E>                                         374,935
<DEPRECIATION>                                 130,574
<TOTAL-ASSETS>                                 273,306
<CURRENT-LIABILITIES>                           45,392
<BONDS>                                         11,752
<COMMON>                                         3,361
<PREFERRED-MANDATORY>                            2,319
<PREFERRED>                                          0
<OTHER-SE>                                     205,157
<TOTAL-LIABILITY-AND-EQUITY>                   273,306
<SALES>                                        221,635
<TOTAL-REVENUES>                               223,331
<CGS>                                           99,439
<TOTAL-COSTS>                                  184,102
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,295
<INCOME-PRETAX>                                 39,229
<INCOME-TAX>                                    15,377
<INCOME-CONTINUING>                             23,852
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    23,852
<EPS-BASIC>                                      .88
<EPS-DILUTED>                                      .85


</TABLE>
§ 20.80 Applicability of limitations on exemptions. ( a ) The limitations on exemptions established in this subpart shall apply to all Food and Drug Administration records, except as specifically provided herein. Accordingly, a record that is ordinarily exempt from public disclosure in accordance with the provisions in subpart D of this part is available for such disclosure to the extent that it falls within a limitation on the exemption contained in this subpart. For example, an investigatory record that is ordinarily exempt from disclosure under § 20.64 is disclosable to Congress in accordance with the provisions of § 20.87.
( b ) Disclosure of a record to any member of the public pursuant to the provisions in § 20.81, data and information previously disclosed to the public, in § 20.82, discretionary disclosure by the Commissioner, and in § 20.83, disclosure pursuant to a court order, shall involve the rule established in § 20.21 that the record shall be made available for disclosure to all members of the public who request it. Disclosure of a record only to the limited categories of persons and under the conditions specified in § 20.84, special government employees, in § 20.85, other Federal government departments and agencies, in § 20.86, in camera disclosure in administrative or court proceedings, in § 20.87(b), Congress, in § 20.88, State and local government officials, in § 20.89, foreign government officials, and in § 20.90, contractors, which does not result in disclosure of the record to any member of the public in an authorized manner, shall not invoke the rule established in § 20.21.
( c ) Disclosure to government employees and special government employees of records exempt from public disclosure shall subject those persons to the same restrictions with respect to the disclosure of such records as any Food and Drug Administration employee.
( d ) In the case of a record in a Privacy Act Record System, as defined in § 21.3(c) of this chapter: ( 1 ) The availability to an individual, as defined in § 21.3(a), of a record about himself that is retrieved by the individual's name or other personal identifier and is contained in a Privacy Act Record System shall be subject to the special requirements of part 21 of this chapter (the privacy regulations) and shall not be subject to the exemptions in subpart D of this part except that where the system is exempt and the requested record is not available under § 21.61 of this chapter, the provisions of this part shall apply.
( 2 ) The availability of a record about an individual to persons other than the individual who is the subject of the record shall be subject to the special requirements of part 21, subpart G, of this chapter (restrictions on disclosure in the privacy regulations), and shall not be subject to the limitations on exemptions in this subpart except as provided in part 21, subpart G, of this chapter.
<TABLE> <S> <C>

<ARTICLE> 9
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                          12,771
<INT-BEARING-DEPOSITS>                          23,406
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                     50,855
<INVESTMENTS-CARRYING>                           9,733
<INVESTMENTS-MARKET>                             9,857
<LOANS>                                        132,126
<ALLOWANCE>                                      1,419
<TOTAL-ASSETS>                                 233,978
<DEPOSITS>                                     188,235
<SHORT-TERM>                                    16,644
<LIABILITIES-OTHER>                              2,303
<LONG-TERM>                                      4,211
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        16,069
<OTHER-SE>                                       6,516
<TOTAL-LIABILITIES-AND-EQUITY>                 233,978
<INTEREST-LOAN>                                 13,167
<INTEREST-INVEST>                                2,937
<INTEREST-OTHER>                                   843
<INTEREST-TOTAL>                                16,947
<INTEREST-DEPOSIT>                               5,186
<INTEREST-EXPENSE>                               5,917
<INTEREST-INCOME-NET>                           11,030
<LOAN-LOSSES>                                      236
<SECURITIES-GAINS>                                  20
<EXPENSE-OTHER>                                  7,153
<INCOME-PRETAX>                                  5,867
<INCOME-PRE-EXTRAORDINARY>                       5,867
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     3,840
<EPS-PRIMARY>                                     0.99
<EPS-DILUTED>                                     0.99
<YIELD-ACTUAL>                                    8.77
<LOANS-NON>                                        173
<LOANS-PAST>                                       447
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                 1,201
<CHARGE-OFFS>                                       32
<RECOVERIES>                                        14
<ALLOWANCE-CLOSE>                                1,419
<ALLOWANCE-DOMESTIC>                                 0
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                          1,419
        

</TABLE>
[Federal Register Volume 75, Number 40 (Tuesday, March 2, 2010)]
[Notices]
[Page 9429]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4224]


-----------------------------------------------------------------------

DEPARTMENT OF THE INTERIOR

Bureau of Land Management

[LLORW00000 L16100000.DO0000.WBSLXSS073H0000; GP10-0139]


Notice of Public Meeting, Eastern Washington Resource Advisory 
Council Meeting

AGENCY: Bureau of Land Management, Interior.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Land Policy and Management Act 
of 1976 and the Federal Advisory Committee Act of 1972, the U.S. 
Department of the Interior, Bureau of Land Management (BLM) Eastern 
Washington Resource Advisory Council (EWRAC) will meet as indicated 
below.

DATES: Meeting will take place on March 25, 2010, from 10 a.m. to 2 
p.m.

ADDRESSES: The meeting will be held at The Potato Commission, 108 S. 
Interlake Rd., Moses Lake, Washington 98837-2950.

FOR FURTHER INFORMATION CONTACT: BLM Spokane District, 1103 N. Fancher 
Rd., Spokane Valley, WA 99212, or call (509) 536-1200.

SUPPLEMENTARY INFORMATION: The meeting will be open to the public. It 
will begin at 10 a.m. and end at 2 p.m. on March 25. Members of the 
public will have an opportunity to address the EWRAC at 10 a.m. 
Discussion will focus on the Spokane and San Juan Islands Resource 
Management Plan.

Robert B. Towne,
Spokane District Manager.
[FR Doc. 2010-4224 Filed 3-1-10; 8:45 am]
BILLING CODE 4310-33-P